MétaCan
Menu
Retour à la cohorte
Enregistrement W4410403331 · doi:10.1227/neu.0000000000003510

Letter: Commentary: Is It Justified to Sacrifice the Pituitary Stalk During Craniopharyngioma Surgery? A Systematic Review and Meta-Analysis

2025· review· en· W4410403331 sur OpenAlexaff
Mohammad Elbaroody, Mohamed Dokhan, Andrea Kassay, Ahmed Ezzat, Ahmed A. Marei, Amr Helmy Eldessouky, Basem Ismail Alhayen, Muhammad Algabrouny, Adham Ezz, Mohamed F. Alsawy, Ehab El Refaee, Mohamed A. R. Soliman

Notice bibliographique

RevueNeurosurgery · 2025
Typereview
Langueen
DomaineMedicine
ThématiquePituitary Gland Disorders and Treatments
Établissements canadiensUniversity of Toronto
Organismes subventionnairesnon disponible
Mots-clésMedicineCraniopharyngiomaPituitary stalkMeta-analysisGeneral surgeryPituitary neoplasmSurgeryPituitary glandInternal medicine

Résumé

récupéré en direct d'OpenAlex

To the Editor: We thank Abou-Al-Shaar et al,1 for their valuable comments on our study.2 Unsurprisingly, we noted that most of their comments have been extensively discussed both in the Discussion and Limitations sections. We designed this meta-analysis to answer a specific question of the impact of pituitary stalk (PS) sacrifice and preservation on postoperative endocrine functions and/or tumor recurrence or progression based on “the current literature,” so it is logical to include “only” the studies that directly compared the PS sacrifice vs no sacrifice and answered this question in their results. We mentioned clearly in the Limitations section that our inclusion criteria excluded many highly valuable craniopharyngioma studies for example, but not limited to, a study by Algattas et al including 62 patients using the Extended Endonasal Approach (EEA) mentioned only some data about PS infiltration and did not mention details about the PS preservation or sacrifice and the impact of each,3 a study by Koutourousiou et al4 including 64 patients, by Cavallo et al5 including 103 patients, and by Chakrabarti et al6 including 86 patients, and all of them did not mention data regarding PS preservation or sacrifice. So, one can understand that the main core of the issue is the reporting of craniopharyngioma studies in the literature, and Abou-Al-Shaar et al1 admitted this problem. Although the authors1 initially assumed that our methodology would not allow us to accurately address the questions regarding endocrine preservation or recurrence, a recent meta-analysis using a different methodology reached similar conclusions. This meta-analysis, which investigated the effects of PS preservation vs sacrifice, found that PS preservation significantly reduced the risk of Diabetes Insipidus (DI) at the last follow-up and helped preserve normal anterior pituitary function. Furthermore, no significant differences were observed between the preservation and sacrifice groups regarding incomplete resection or tumor recurrence.7 Moreover, a recent preprint of a study on 99 patients with papillary craniopharyngioma from 14 skull base expert centers in the United States reported that permanent arginine vasopressin deficiency was significantly related to PS sacrifice and patients with preserved PS showed lower rates of permanent 90-day panhypopituitarism including in arginine vasopressin deficiency, adrenal insufficiency, and hypothyroidism, and they did not comment on tumor recurrence/progression in relation to PS sacrifice or preservation.8 Knowing the importance of preoperative endocrine dysfunction, we mentioned that many authors reported that the patients with preserved PS and had preoperative severe hypopituitarism (≥3 hormonal deficiency) or panhypopituitarism did not show any postoperative endocrine recovery. We agree with the authors1 that postoperative endocrine dysfunction has many forms, and patients with DI alone should be treated equally or grouped with patients with panhypopituitarism; however, we mentioned below in Table (2) that postoperative endocrine dysfunction refers to patients who had partial hypopituitarism, panhypopituitarism, and/or DI. On the same ground, the other meta-analysis with a different methodology reached the same conclusion of the evident effect of stalk sacrifice on long-term DI.7 We agree with the authors1 that patients with recurrent craniopharyngioma were known to have a higher incidence of pituitary dysfunction and DI compared with primary craniopharyngiomas; they should not be grouped. However, those studies were 50% of our meta-analysis, and the other 50% included patients with primary craniopharyngioma, careful looking at the numbers in the table, one will realize that the separation of two groups mostly will not add any difference to the study objective. The authors1 stated that the entire topic of PS preservation has become more relevant with the increased ability to distinguish the stalk using the EEA, but the authors neglected the more important part “reporting operative data of the stalk”: preserved, sacrificed, shredded, infiltrated, or not identified at all, and the impact of each finding on endocrine function and recurrence. On the same ground of defective reporting in literature, many studies on craniopharyngioma reporting the EEA did not mention clear data about the impact of PS sacrifice or preservation.3-6 We neither adopt nor defend the concept of subtotal resection followed by radiation therapy as a primary paradigm rather than gross total resection for craniopharyngioma. The literature is flooded with the debate of the superiority of both concepts, and each school rationalizes its opinion with results. We mentioned that we recommend PS preservation whenever possible, especially in patients with normal preoperative endocrine dysfunction, and this should not contradict gross total resection. Our results showed that PS sacrifice did not affect the recurrence or progression of craniopharyngioma, an experienced neurosurgeon should weigh each decision and tailor this important step according to each patient. In accordance, expert opinion in the field of craniopharyngioma is respected. Our article is a meta-analysis of the existing literature, rather than a clinical study, and as such, it is subject to the limitations inherent in the clinical studies we reviewed. Many of these studies are case series or cohort studies, with only a few directly comparing outcomes of surgeries with and without stalk sacrifice. Until more robust comparative studies with better outcome reporting emerge, the current body of evidence will remain a significant reference point. In conclusion, given the under-reporting of stalk sacrifice, our study lays the foundation for understanding the existing data in the literature and highlights the need for further research with rigorous reporting on stalk sacrifice and its outcomes. We also appreciate the authors' call for future prospective studies from experienced centers to report their outcomes more systematically.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,016
score de la tête « metaresearch » (Gemma)0,123
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Méta-analyse · Signal consensuel: aucune
GenreSignal candidat: Synthèse · Signal consensuel: aucune
Score de désaccord entre enseignants0,023
Score d'incertitude au seuil0,087

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0160,123
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0040,003
Bibliométrie0,0020,003
Études des sciences et des technologies0,0020,002
Communication savante0,0030,005
Science ouverte0,0050,002
Intégrité de la recherche0,0230,014
Charge utile insuffisante (le modèle a refusé de juger)0,0140,005

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,082
Tête enseignante GPT0,338
Écart entre enseignants0,257 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeMéta-analyse
Domainenon disponible
GenreSynthèse

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueNeurosurgeryMême sujetPituitary Gland Disorders and TreatmentsTravaux en français237 207